Search

USA: Pharma Kingchem Life Science Invests 3 Million Plus Dollars to Acquire Apiscent Labs

| Editor: Ahlam Rais

The deal will enable Kingchem to establish its maiden R&D and GMP-manufacturing capabilities in the US. In addition to this, the firm will also invest another 2 million dollars for capacity expansion and setting up a new lab.

Related Companies

The newly acquired assets will allow Kingchem to offer GMP service to the pharmaceutical industry.
The newly acquired assets will allow Kingchem to offer GMP service to the pharmaceutical industry.
(Source: Deposit Photos)

USA – Kingchem Life Science of Allendale has announced its recent acquisition of Apiscent Laboratories. A total investment of over 3 million dollars was made regarding the business assets and real estate. A new company, Kingchem Laboratories—a subsidiary of Kingchem Life Science—will continue to employ the current staff. In addition, at least 10 new employees, including QA, R&D and production supervisors and operators, will be hired in the coming months.

The acquisition gives Kingchem its initial R&D and GMP-manufacturing capabilities in the United States. Further investments of at least 2 million dollars are planned for the Wisconsin facility over the next 1-2 years for equipment upgrading, capacity expansion, as well as construction of a new GMP kilo lab.

The newly acquired assets will allow Kingchem to offer GMP service to the pharmaceutical industry.

(ID:45633357)